180 related articles for article (PubMed ID: 15954424)
1. [Japanese encephalitis vaccine].
Nerome R; Kurane I
Nihon Rinsho; 2005 May; 63 Suppl 5():647-53. PubMed ID: 15954424
[No Abstract] [Full Text] [Related]
2. [Diagnostic tests: Japanese encephalitis virus and the other flavivirus].
Nerome R; Takasaki T
Nihon Rinsho; 2005 Jul; 63 Suppl 7():336-8. PubMed ID: 16111267
[No Abstract] [Full Text] [Related]
3. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis.
Kumar R; Tripathi P; Rizvi A
N Engl J Med; 2009 Apr; 360(14):1465-6. PubMed ID: 19339732
[No Abstract] [Full Text] [Related]
4. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
Konishi E; Yamaoka M; Kurane I; Mason PW
Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
6. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
7. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
Bharati K; Rani R; Vrati S
Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice.
Yang DK; Kweon CH; Kim BH; Lim SI; Kwon JH; Kim SH; Song JY; Han HR
J Vet Sci; 2005 Jun; 6(2):125-33. PubMed ID: 15933432
[TBL] [Abstract][Full Text] [Related]
10. [Construction of infectious Japanese encephalitis virus clone based on the cDNA template of the attenuated live vaccine production strain SA14-14-2].
Zeng M; Jia LL; Yu YX; Dong GM; Liu WX; Wang ZW; Li DF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):9-11. PubMed ID: 16201461
[TBL] [Abstract][Full Text] [Related]
11. [Japanese encephalitis virus and other flaviviruses].
Takasaki T
Nihon Rinsho; 2010 Jun; 68 Suppl 6():363-6. PubMed ID: 20942080
[No Abstract] [Full Text] [Related]
12. Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice.
Verma SK; Kumar S; Gupta N; Vedi S; Bhattacharya SM; Lakshmana Rao PV
Vaccine; 2009 Nov; 27(49):6905-9. PubMed ID: 19761840
[TBL] [Abstract][Full Text] [Related]
13. Japanese encephalitis in Western Europe.
Reppel M; Landreh L; Gottschalk S; Schunkert H; Kurowski V; Seidel G
Clin Neurol Neurosurg; 2009 May; 111(4):373-5. PubMed ID: 19095347
[TBL] [Abstract][Full Text] [Related]
14. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge.
Chia SC; Leung PS; Liao CP; Huang JH; Lee ST
Microb Pathog; 2001 Jul; 31(1):9-19. PubMed ID: 11427032
[TBL] [Abstract][Full Text] [Related]
15. Selection of immunodominant fragments from envelope gene for vaccine against Japanese encephalitis virus in DNA priming-protein boosting protocols.
Chen CT; Yi YC; Chiang SC; Liu KC; Lin YL; Lee ST
Microb Pathog; 2005; 38(2-3):53-62. PubMed ID: 15748807
[TBL] [Abstract][Full Text] [Related]
16. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
17. [Japanese encephalitis].
Takegami T
Uirusu; 2003 Jun; 53(1):25-30. PubMed ID: 14556499
[No Abstract] [Full Text] [Related]
18. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus.
Ge FF; Qiu YF; Yang YW; Chen PY
Arch Virol; 2007 Jan; 152(1):125-35. PubMed ID: 16862385
[TBL] [Abstract][Full Text] [Related]
19. Japanese Encephalitis Vaccines: WHO position paper – February 2015.
Wkly Epidemiol Rec; 2015 Feb; 90(9):69-87. PubMed ID: 25726573
[No Abstract] [Full Text] [Related]
20. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
Ferguson M; Johnes S; Li L; Heath A; Barrett A
Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
